Thirumala‐Devi Kanneganti

3 ta ish

St. Jude Children's Research Hospital

1. NLRP3 inflammasome in cancer and metabolic diseases

   Bhesh Raj Sharma, Thirumala‐Devi Kanneganti

   Sharh maqola20214 iqtibos

   ABIABI:AkademIndex/2026.other.253664

2. Innate immunity: the first line of defense against SARS-CoV-2

   Michael Diamond, Thirumala‐Devi Kanneganti

   Sharh maqolaOAOchiq kirish20223 iqtibos

   ABIABI:AkademIndex/2026.other.204793

3. The ‘cytokine storm’: molecular mechanisms and therapeutic prospects

   Rajendra Karki, Thirumala‐Devi Kanneganti

   Sharh maqolaOAOchiq kirish20212 iqtibos

   ABIABI:AkademIndex/2026.other.204785